Sutherland Medical Center Report issue

For profit Phase 4
Founded: Taren Point Australia (1958)

Organization Overview

First Clinical Trial
2020
NCT04492748
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sutherland Medical Center

Active Ingredients

Drugs in Phase 4 Trials (2)

collagen (1 trial)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rotator Cuff Injuries (Phase 4)

Tendinopathy (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2